April 20 (Reuters) - Samsara Vision Inc SMSA.O :
* SAMSARA VISION TO INITIATE A U.S. PMA SUPPLEMENTAL STUDY OF THE SING IMT™, A NEW-GENERATION TECHNOLOGY FOR AGE-RELATED MACULAR DEGENERATION
* SAMSARA VISION - ANNOUNCED FDA APPROVAL TO INITIATE U.S.-BASED, PMA SUPPLEMENTAL STUDY
* SAMSARA VISION INC - CONCERTO TRIAL WILL INCLUDE UP TO TWENTY CLINICAL SITES ACROSS UNITED STATES
Source text for Eikon: ID:nBw5JsrLja Further company coverage: SMSA.O
